Everolimus doubles PFS after sorafenib/sunitinib resistance: Commentary
Publication
, Journal Article
George, DJ
Published in: Oncology Report
September 1, 2008
Duke Scholars
Published In
Oncology Report
EISSN
1548-5323
ISSN
1548-5323
Publication Date
September 1, 2008
Issue
FALL
Start / End Page
43
Related Subject Headings
- Oncology & Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
George, D. J. (2008). Everolimus doubles PFS after sorafenib/sunitinib resistance: Commentary. Oncology Report, (FALL), 43.
George, D. J. “Everolimus doubles PFS after sorafenib/sunitinib resistance: Commentary.” Oncology Report, no. FALL (September 1, 2008): 43.
George DJ. Everolimus doubles PFS after sorafenib/sunitinib resistance: Commentary. Oncology Report. 2008 Sep 1;(FALL):43.
George, D. J. “Everolimus doubles PFS after sorafenib/sunitinib resistance: Commentary.” Oncology Report, no. FALL, Sept. 2008, p. 43.
George DJ. Everolimus doubles PFS after sorafenib/sunitinib resistance: Commentary. Oncology Report. 2008 Sep 1;(FALL):43.
Published In
Oncology Report
EISSN
1548-5323
ISSN
1548-5323
Publication Date
September 1, 2008
Issue
FALL
Start / End Page
43
Related Subject Headings
- Oncology & Carcinogenesis